Cambridge, United Kingdom · Founded 2018 · Privately Held (backing)
Developer of a drug discovery and cell microcarrier platform designed to revolutionize adherent cell screening. Semarion is based in Cambridge, United Kingdom and was founded in 2018. Its last reported valuation was $39.6 million in Mar 2025. It has raised $7 million.
Last reported valuation
$39.6M
Oct 2026
Priced at
—
Total raised
$7.0M
Last round
—
Team — not yet on record
No current team members for Semarion are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Semarion with a free account
·Watch Semarion: the Monday email on marks, rounds and moves
